Abbreviations used in this paper: HA, influenza virus hemagglutinin; mPTS, peroxisomal membrane-targeting signal; PMP, peroxisomal membrane protein; PNS, postnuclear supernatant; SB, semi-intact cell buffer; TM, transmembrane.

Introduction
============

Of over a dozen subcellular compartments in eukaryotic cells, the peroxisome is a spherical single membrane--bounded organelle that functions in essential metabolic pathways, including the β oxidation of very long chain fatty acids and the biosynthesis of ether lipids such as plasmalogens ([@bib46]). Peroxisomal matrix and membrane proteins (PMPs) are synthesized on free polysomes in the cytosol and are posttranslationally imported into peroxisomes ([@bib22]). The import of matrix proteins involves the recognition of two distinct topogenic signals, tripeptide peroxisomal targeting signal type 1 and nonapeptide peroxisomal targeting signal type 2, by their respective cytosolic receptors, Pex5p and Pex7p, followed by the translocation of such complexes via peroxisomal membrane importomers, which include Pex14p and RING peroxins ([@bib10]; [@bib29]; [@bib7]). Genetic phenotype complementation assays of peroxisome membrane-deficient mutants of yeast and mammalian cells led to the isolation of Pex3p, Pex16p, and Pex19p, which are all indispensable for PMP import ([@bib12]; [@bib2]; [@bib14]; [@bib9]; [@bib27]; [@bib38]; [@bib8]; [@bib31]). In contrast to the matrix protein import, the molecular mechanisms underlying the assembly of PMPs remain poorly defined ([@bib6]; [@bib34]).

[@bib17] recently proposed that at least two different pathways, termed class I and class II, mediate PMP import. The class I pathway depends on Pex19p, a predominantly cytosolic protein that binds to the internal regions of peroxisomal membrane-targeting signal (mPTS) in multiple PMPs and functions as a chaperone and/or soluble receptor for newly synthesized PMPs. Pex3p was shown to be a membrane import receptor for class I PMPs by means of *PEX3* RNAi ([@bib3]). The class II pathway was postulated to be independent of Pex19p and Pex3p and includes Pex3p as the only PMP cargo yet identified. Mammalian Pex3p is a 42-kD peroxisomal integral membrane protein containing three hydrophobic regions, of which two domains residing at the N-terminal part are reported as transmembrane 1 (TM1) and TM2 ([@bib18]; [@bib8]; see also [Fig. 1 D](#fig1){ref-type="fig"}). Pex19p appears not to function as a chaperone and an import receptor for the Pex3p mPTS comprising the N-terminal first TM1 region. Instead, Pex19p binds to the TM2 part of Pex3p ([@bib3]), implying that Pex19p may be required for preventing the aggregation of Pex3p-TM2. In contrast, in the yeast *Saccharomyces cerevisiae*, Pex3p (ScPex3p) fused to yellow fluorescent protein was constitutively transported to peroxisomes via the ER, where Pex19p was then required for the exit of Pex3p from the ER ([@bib13]). However, the precise role of ScPex19p in such processes has remained elusive.

In the present work, we first investigated whether Pex19p has a chaperone activity toward full-length Pex3p as for the class I PMPs. Our results show that Pex19p stabilizes newly synthesized full-length Pex3p in the cytosol and that this Pex3p--Pex19p complex is competent in the peroxisome-targeting assay using semi-intact CHO-K1 cells. Moreover, knockdown of endogenous Pex19p interferes with peroxisomal targeting of Pex3p. In vitro import assay, Pex3p is directly imported to peroxisomes in a Pex16p-dependent manner, whereas the knockdown of Pex16p significantly abrogates peroxisomal targeting of Pex3p. Based on these and earlier findings, we present a new model for membrane assembly of peroxisomes.

Results
=======

Pex19p stabilizes Pex3p in the cytosol
--------------------------------------

Coexpression in CHO-K1 cells of full-length Pex3p fused to EGFP at the C terminus (Pex3p-EGFP) with N-terminally tandem influenza virus hemagglutinin (HA)--tagged Pex19p (HA-Pex19p; [@bib26]) gave rise to cytosolic localization of Pex3p-EGFP, whereas coexpression with HA-Pex19pΔN23 (Pex19p truncated in the N-terminal residues 1--23 and defective in binding to Pex3p \[[@bib28]\]) resulted in localization of Pex3p-EGFP to peroxisomes ([Fig. 1 A](#fig1){ref-type="fig"}). This was compatible with the findings that Pex3p interacted with the N-terminal part of Pex19p in the yeast and mammalian two-hybrid assays ([@bib4]; [@bib3]). Compared with HA-Pex19pΔN23--expressing and mock cells, the expressed level of Flag-Pex3p was significantly elevated in HA-Pex19p--expressing cells ([Fig. 1 B](#fig1){ref-type="fig"}, lanes 1--3), where Flag-Pex3p was localized more in the cytosol in a form of Pex3p--Pex19p complexes (lanes 4--10). HA-Pex19p was likewise increased in the organelle fraction, more likely reflecting the HA-Pex19p binding to a higher level of Flag-Pex3p localized to peroxisomes ([Fig. 1 B](#fig1){ref-type="fig"}, lane 6; [@bib28]). Furthermore, to determine whether Pex19p stabilizes the full-length Pex3p, we performed a pulse-chase experiment. CHO-K1 cells expressing Flag-Pex3p-HA, together with and without Pex19p, were pulse labeled for 20 min with \[^35^S\]methionine and \[^35^S\]cysteine, and then chased for 6 h. Flag-Pex3p-HA including ^35^S-Flag-Pex3p-HA was immunoprecipitated, analyzed by immunoblot and autoradiography, and quantitated by a densitometer. ^35^S-Flag-Pex3p-HA showed an apparent half-life of ∼6 h when coexpressed with Pex19p, in contrast to ∼2 h without Pex19p ([Fig. 1 C](#fig1){ref-type="fig"}), suggesting that Flag-Pex3p-HA was stabilized by Pex19p. Moreover, a Flag-Pex3p-HA mutant deleted in the TM2 domain, including Pex19p-docking region, failed to form the cytosolic complex with Pex19p, whereas another TM3-truncated variant was discernible in the cytosol as the Flag-Pex3p-HA ([Fig. 1 D](#fig1){ref-type="fig"}). These results strongly suggested that the TM2 domain was required for Pex19p-mediated stabilization of Pex3p. Collectively, it is most likely that Pex19p also functions as a chaperone for Pex3p as for the class I PMPs. Our conclusion was consistent with the observation that Pex3p and Pex14p bound to Pex19p in a competitive manner ([@bib35]).

![**Pex19p stabilizes Pex3p in the cytosol by forming Pex3p--Pex19p complexes.** (A) CHO-K1 cells were transfected with *PEX3-EGFP* together with *HA-PEX19* (a and b) or *HA-PEX19ΔN23* encoding HA-Pex19p truncated in amino acid residues 1--23 (c and d). After cell fixation, HA-Pex19p and Pex3p-EGFP were detected with anti-HA antibody (a and c) and by EGFP fluorescence (b and d), respectively. Bars, 10 μm. (B, left) CHO-K1 cells were transfected with *Flag-PEX3* plus a mock vector (lane 1), *HA-PEX19* (lane 2), or *HA-PEX19ΔN23* (lane 3). Cell lysates were analyzed by SDS-PAGE and immunoblot. α-Tubulin was used for a protein loading control. (middle) Organelle (P) and cytosol (S) fractions from PNS of CHO-K1 cells transfected with *Flag-PEX3* (lanes 4 and 5) or *Flag-PEX3* and *HA-PEX19* (lanes 6 and 7) were likewise analyzed. Separation of organelle and cytosol fractions were assessed with Pex14p and lactate dehydrogenase (LDH). Note that coexpression of Pex3p with Pex19p enhanced the level of Pex3p in the cytosol. (right) Immunoprecipitation of HA-Pex19p was performed with anti-HA antibody (lane 10) or preimmune serum (lane 9) from the cytosol fraction of CHO-K1 cells that had been cotransfected with *Flag-PEX3* and *HA-PEX19*. Immunoprecipitates were analyzed with antibodies to Flag and HA. (input) 10% of the cytosol used for immunoprecipitation. (C) CHO-K1 cells transfected with *Flag-PEX3-HA* together with *PEX19* (top) or a mock vector (middle) were pulse labeled for 20 min with \[^35^S\]methionine and \[^35^S\]cysteine and chased for the time indicated at the top. Immunoprecipitates using anti-HA antibody were analyzed by SDS-PAGE followed by autoradiography and immunoblot. Molecular mass of Flag-Pex3p-HA is 45 kD. ^35^S-Flag-Pex3p-HA level at each time point, relative to Flag-Pex3p-HA assessed with anti-HA antibody, was quantitated and represented as a percentage of that at chase-starting time (bottom). Values are means ± SD of three experiments. (D) Pex19p-mediated stabilization of Pex3p in the cytosol requires the TM2-containing Pex19p-binding region. (top) A schematic view of rat Pex3p, where the potential TM3-encompassing residues at 311--332 are also indicated. (bottom) CHO-K1 cells were transfected with *Flag-PEX19* together with *HA-PEX3ΔTM2* or *HA-PEX3ΔTM3*. Cells were fixed and stained with antibodies to Flag (a and c) and HA (b and d). Bars, 10 μm.](jcb1831275f01){#fig1}

Pex19p is involved in peroxisomal targeting of Pex3p
----------------------------------------------------

To verify whether Pex19p is responsible for peroxisomal targeting of newly synthesized Pex3p, we next investigated Pex3p translocation in cells where Pex19p was knocked down. In HEK293 cells transfected with control siRNA, both Pex3p-Myc and Pex3p(1--50)-Myc were colocalized with Pex14p, hence inciting proper translocation of Pex3p-Myc and Pex3p(1--50)-Myc to peroxisomes ([Fig. 2 B, g--l](#fig2){ref-type="fig"}). Pex19p was brilliantly discernible as numerous punctate structures colocalized with Pex14p (peroxisomes) compared with relatively weak and diffused staining of the cytosol ([Fig. 2 B, h and k](#fig2){ref-type="fig"}). Subcellular fractionation of HEK293 cell homogenates indicated that Pex19p distributed nearly equally between the organelle and cytosol fractions (unpublished data), thereby confirming the morphological observation. In contrast, in Pex19p knockdown cells ([Fig. 2 A](#fig2){ref-type="fig"}), Pex3p-Myc was discernible predominantly in other organelles apparently including mitochondria, whereas Pex3p(1--50)-Myc was correctly imported into peroxisomes ([Fig. 2 B, a--f](#fig2){ref-type="fig"}). Furthermore, we assessed Pex3p-Myc and Pex3p(1--50)-Myc import-competent cells in several hundreds of cells where Pex19p was knocked down as well as in randomly selected cells transfected with a control siRNA. Statistic analysis of these data confirmed that the elimination of Pex19p gave rise to the specific defect in the import to peroxisomes of full-length Pex3p, but not Pex3p(1--50)-Myc ([Fig. 2 C](#fig2){ref-type="fig"}). Collectively, these results demonstrated that Pex19p was essential for peroxisomal targeting of newly synthesized full-length Pex3p in vivo.

![**The effect of Pex19p on the localization of Pex3p.** (A) HEK293 cells were transfected with *PEX19* RNAi or control RNAi twice at a 24-h interval (the first siRNA treatment is day 0). Cells were lysed each day after the siRNA treatment, and equivalent volumes of total cell lysates were analyzed by SDS-PAGE and immunoblot. Tom20 was used for a protein loading control. (B) Depletion of Pex19p abrogates Pex3p targeting in vivo. On day 2 after siRNA treatment, *PEX19* RNAi (a--f)- or control RNAi (g--l)-transfected cells were retransfected with *PEX3-Myc* (a--c and g--i) or *PEX3(1--50)-Myc* (d--f and j--l). Pex3p-Myc, Pex3p(1--50)-Myc, Pex19p, and Pex14p were detected by cell staining using antibodies to Myc (a, d, g and j), Pex19p (b, e, h and k), and Pex14p (c, f, i and l), respectively. Bars, 10 μm. Note that in HEK293 cells, endogenous Pex19p was detected as particles, colocalized with the peroxisomal marker Pex14p. (C) Control siRNA-transfected or -mediated Pex19p knockdown cells were assessed for the level and subcellular localization of Pex3p-Myc and Pex3p(1--50)-Myc by immunostaining. (left) Cell phenotypes with respect to the localization of Pex3p-Myc were classified into three types, peroxisomal, nonperoxisomal, and both, and was represented as a percentage of total cells counted. Values are means ± SD of three experiments. Control siRNA, *n* = 462; *PEX19* siRNA, *n* = 454. (right) Localization of Pex3p(1--50)-Myc was likewise verified. Control siRNA, *n* = 542; *PEX19* siRNA, *n* = 416.](jcb1831275f02){#fig2}

Pex16p functions as a membrane receptor for Pex3p--Pex19p complexes
-------------------------------------------------------------------

To investigate whether Pex3p--Pex19p complexes in the cytosol are competent to translocate to peroxisomes, we performed PMP-targeting assay at 26°C for 1 h using the semi-intact CHO-K1 cells that had been permeabilized with digitonin. After incubation of the semi-intact cells with the cytosol fraction containing Pex3p-Myc and HA-Pex19p, both proteins were detected in a manner superimposable on Pex14p ([Fig. 3 A](#fig3){ref-type="fig"} and Fig. S1 A, available at <http://www.jcb.org/cgi/content/full/jcb.200806062/DC1>), thereby indicating that Pex3p--Pex19p complexes and possibly Pex19p were transported to peroxisomes. As a control, when only Pex3p-Myc was expressed by transient transfection of *PEX3-Myc* to CHO-K1 cells, Pex3p-Myc was not found in the cytosol fraction, but was partly aggregated or mislocalized to mitochondria (unpublished data), as reported previously ([@bib35]; [@bib28]). Transiently expressed HA-Pex19p was mostly in the cytosol and competent in targeting to peroxisomes, at endogenous or ectopically expressed Pex3p level in the targeting assay using semi-intact cells (unpublished data). Next, we search for a potential membrane receptor for Pex3p--Pex19p complexes, using the semi-intact cells that had been ectopically and transiently expressed with EGFP-fused or HA-tagged PMPs including membrane-integrated peroxins. To more readily and specifically detect the targeting of Pex3p-Myc to ectopically expressed PMPs on peroxisomes, the targeting assay was performed at 4°C for 30 min, under which condition, using mock-transfected CHO-K1 cells, the targeting of Pex3p-Myc and HA-Pex19p complex to "naive" peroxisomes was relatively less discernible (unpublished data). Upon incubation at 4°C for 30 min, peroxisomal localization of Pex3p-Myc was enhanced only in the cells expressing EGFP-Pex16p in a superimposable manner ([Fig. 3 B](#fig3){ref-type="fig"} and Fig. S1 B), with five- to sixfold increase in the level of targeted Pex3p-Myc as compared with the control cells where Pex3p-Myc was barely discernible (Fig. S2, available at <http://www.jcb.org/cgi/content/full/jcb.200806062/DC1>), thereby suggesting that Pex16p is a receptor for Pex3p--Pex19p complexes. It was noteworthy that the Pex3p-Myc targeted to peroxisomes at 4°C was barely integrated to membranes as assessed by the sodium carbonate extraction ([@bib5]; unpublished data). In the similar assay using CHO-K1 cells stably expressing Pex16p-HA (unpublished data; Honsho, M.), after 1-h targeting incubation at 0°C, Pex3p-Myc became resistant to the alkaline extraction upon a chase reaction for 1 h at 26°C, but not 0°C, with no difference between the presence of ATP plus ATP-regenerating system and AMP-PNP (Fig. S3), thereby indicating the integration of Pex3p-Myc to peroxisome membranes in a manner dependent on temperature but independent of ATP hydrolysis.

![**Pex16p functions as a membrane receptor for Pex3p--Pex19p complexes.** (A) Pex3p-targeting assay was performed at 26°C for 1 h using semipermeabilized CHO-K1 cells and cytosol fraction containing Pex3p-Myc and HA-Pex19p, as described in Materials and methods. Pex3p-Myc, HA-Pex19p, and Pex14p were detected with antibodies to Myc (a), HA (b), and Pex14p (c), respectively. Bar, 10 μm. (B) Pex3p-targeting assay using the semipermeabilized cells was done at 4°C for 30 min. (left) Semipermeabilized cells used were CHO-K1 cells expressing EGFP-fused membrane peroxins (Pex-EGs) and PMPs (PMP-EGs). The assays were performed with cytosol fraction containing Pex3p-Myc and HA-Pex19p. Membrane peroxins and Pex3p-Myc were visualized by GFP fluorescence and staining with anti-Myc antibody, respectively. (right) Semi-intact CHO-K1 cells expressing HA-tagged membrane peroxins were likewise verified with cytosol fraction containing Pex3p-Myc and Flag-Pex19p. HA peroxins were detected with anti-HA antibody. All EGFP-fused or HA-tagged membrane peroxins used are biologically active in CHO mutants and human fibroblasts derived from patients with peroxisome biogenesis disorders (not depicted). Bars, 10 μm. Note that ectopic expression of EGFP-Pex16p specifically enhanced the targeting efficiency of Pex3p-Myc. (C) ER-localized Pex16p recruits Pex3p--Pex19p complexes to ER membranes. *SS-HA-PEX16* and *SS-HA-PEX11a* encoding HA-Pex16p and HA-Pex11pα, both N-terminally tagged with the signal sequence of mouse activin type IIA receptor, were expressed in CHO-K1 cells. Cells were semipermeabilized and assayed for Pex3p-Myc targeting as in B. HA-Pex16p (a), Pex3p-Myc (b and d), and HA-Pex11pα (c) were detected by immunostaining. Bars, 10 μm.](jcb1831275f03){#fig3}

In our attempts to detect and/or isolate the endogenous Pex3p--Pex19p complexes in the cytosol, it was very difficult to detect them because of the extremely low level of such transient complexes, in not only wild-type CHO-K1 cells but also *pex16* mutant fibroblasts from the *PEX16*-defective patient with Zellweger syndrome where Pex3p was readily mistargeted to other organelles such as mitochondria (unpublished data).

To assess if Pex16p is sufficient as the membrane receptor for Pex3p--Pex19p complexes, we expressed in ER membranes of CHO-K1 a HA-Pex16p variant of which the N terminus was fused with the signal sequence of mouse activin type IIA receptor ([@bib25]) termed SS-HAPex16p. In the semipermeabilized cells expressing SS-HA-Pex16p, Pex3p-Myc coincided in the localization with SS-HA-Pex16p, not with SS-HA-Pex11pα chosen as a control; hence indicating specific targeting of Pex3p to the ER-localized Pex16p ([Fig. 3 C](#fig3){ref-type="fig"}). We interpreted this finding to mean that Pex16p was sufficient for recruiting Pex3p--Pex19p complexes to peroxisome membranes. Moreover, both N- and C-terminal regions of Pex16p were indispensable for recruiting the Pex3p--Pex19p complexes to peroxisomes as likewise assayed using the semi-intact cell import system (Fig. S4, available at <http://www.jcb.org/cgi/content/full/jcb.200806062/DC1>).

Pex16p functions as a membrane receptor for cytosolic Pex3p--Pex19p complexes
-----------------------------------------------------------------------------

To confirm that Pex3p--Pex19p complexes formed in the cytosol are translocated to peroxisomes, we performed in vitro targeting assay using immunoaffinity-purified Pex3p--Pex19p complexes. From the cytosol fractions from CHO-K1 cells that had been transfected with *PEX3-Myc* and either *Flag-PEX19* or *HA-PEX19*, immunoprecipitation was performed with Flag-agarose. Immunoprecipitates were eluted with Flag peptide. Pex3p-Myc was specifically eluted with Flag-Pex19p ([Fig. 4 A](#fig4){ref-type="fig"}), indicating that Pex3p-Myc formed a complex with Flag-Pex19p. After incubation of the semi-intact cells with the eluted fraction containing Pex3p-Myc--Flag-Pex19p complexes, both proteins were detected in a manner superimposable on Pex14p ([Fig. 4 B, a--c](#fig4){ref-type="fig"}), thereby indicating that Pex3p-Myc--Flag-Pex19p complexes were indeed transported to peroxisomes. Furthermore, we demonstrated that peroxisomal import of Pex3p-Myc--Flag-Pex19p complexes was enhanced in the cells expressing EGFP-Pex16p, with five- to sixfold increase in the level of targeted Pex3p-Myc as compared with the control cells ([Fig. 4 B, d--g](#fig4){ref-type="fig"}), thereby indicating that Pex16p functions as a receptor for cytosolic Pex3p--Pex19p complexes.

![**Pex3p--Pex19p complexes formed in the cytosol are competent to translocate to peroxisomes in a Pex16p-dependent manner.** (A) Purification of cytosolic Pex3p--Pex19p complexes. Immunoprecipitation was performed with anti-Flag IgG-conjugated agarose (Sigma-Aldrich) from the cytosol fractions of CHO-K1 cells that had been transfected with *PEX3-Myc* together with *Flag-PEX19* (lanes 1 and 3) or *HA-PEX19* as a control (lanes 2 and 4). Immunoprecipitates were eluted with Flag peptide and subjected to SDS-PAGE and immunoblotting using antibodies to Myc, Flag, and HA. Note that Pex3p-Myc was specifically immunoprecipitated and coeluted with Flag-Pex19p (lane 3). (B) Cytosolic Pex3p-Myc--Flag-Pex19p complexes are imported to peroxisomes in a Pex16p-dependent manner. In vitro targeting assay was performed at 26°C for 1 h using semipermeabilized CHO-K1 cells (a--c) and *EGFP-PEX16*-transfected CHO-K1 cells (d--f) with the eluted fraction in A (lane 3) containing Pex3p-Myc--Flag-Pex19p complexes. Before the targeting assay, Flag peptide was removed from the eluted fraction by gel filtration chromatography on a Sephadex G-25. Pex3p-Myc, Flag-Pex19p, and Pex14p were detected with antibodies to Myc (a and d), Flag (b), and Pex14p (c and f), respectively. EGFP-Pex16p was detected by EGFP fluorescence (e). Bars, 10 μm. (g) Pex3p-Myc levels in cells expressing EGFP-Pex16p at higher (β) and nearly basal (α) levels were quantitated by calculating the ratio of the integrated fluorescence intensities of Pex3p-Myc to Pex14p using LSM software and shown by taking 1 as the value in the cell (α). Values are means ± SD (*n* = 6).](jcb1831275f04){#fig4}

Pex16p-mediated Pex3p import to peroxisomes in the absence of ER
----------------------------------------------------------------

Next, we investigated whether Pex3p is directly imported into peroxisomes in the absence of ER membranes. We performed in vitro Pex3p import assay at 26°C for 1 h using cell-free synthesized Pex3p-Myc and highly purified peroxisomes from CHO-K1 as well as those from CHO-K1 cells stably expressing HA-Pex16p ([Fig. 5 A](#fig5){ref-type="fig"}). Pex3p-Myc was detected only in peroxisomes not in mitochondrial and rough and smooth microsomal fractions, and the Pex3p-Myc level was elevated severalfold with peroxisomes harboring the ectopically expressed HA-Pex16p ([Fig. 5 B](#fig5){ref-type="fig"}). The Pex3p-Myc in peroxisomes was resistant to the alkaline extraction ([@bib5]), hence indicating that Pex3p was integrated into peroxisome membranes ([Fig. 5 C](#fig5){ref-type="fig"}). These results strongly suggested that Pex3p was directly imported into peroxisomes via Pex3p receptor Pex16p on peroxisomal membranes.

![**Pex3p is directly imported into peroxisomes.** (A) Subcellular fractionation of wild-type CHO-K1 cells and those stably expressing Pex16p-HA. Organelle fractions from respective PNS fractions were separated by OptiPrep density gradient ultracentrifugation as described in Materials and methods. Distribution of peroxisomes, mitochondria, and ER (smooth and rough microsomes) were verified by immunoblotting using antibodies against marker proteins: Pex14p, Tom20, P450 reductase, and Sec61pβ, respectively. Arrowheads and bars indicate the peak fractions of peroxisomes (Ps; lane. 2, top), mitochondria (Mt; lane 6, top), smooth and rough microsomes (sMic and rMic; lanes 9 and 6--8, respectively, top), and peroxisomes harboring Pex16p-HA (Ps+16; lane 2, bottom) that were used for in vitro import assays in B. (B) Pex3p-Myc is directly translocated to peroxisomes in a Pex16p-dependent manner. (left) In vitro Pex3p-Myc import assays were performed using Pex3p-Myc synthesized together with Pex19p in a rabbit reticulocyte-lysate system. Pex3p-Myc was incubated at 26°C for 1 h with equal protein amounts of peroxisomes (lane 3), mitochondria plus rough microsomes (lane 4), smooth microsomes (lane 5), and peroxisomes harboring Pex16p-HA (lane 2), respectively, in SB. The same amount of peroxisome fraction was heat denatured and used as an import-negative control (lane 6). After the reaction, organelles were recovered by centrifugation and analyzed by SDS-PAGE and immunoblot. Targeted Pex3p-Myc levels in each fraction were quantitated using ImageJ software and shown by taking 1 as the value in the peroxisome (lane 3) fraction (bottom). (right) Pex16p expression levels in wild-type and HA-Pex16p--expressing cells were assessed by SDS-PAGE and immunoblotting with anti-Pex16p antibody of equal protein amounts of organelle fractions. Closed and open arrowheads indicate endogenous Pex16p and Pex16p-HA, respectively. Total Pex16p levels were quantitated as in the left panel and shown by taking 1 as the value in the wild-type cells, in which the values are means ± SD of three experiments (bottom). Closed and open bars indicate the relative expression levels of endogenous Pex16p and Pex16p-HA, respectively. (C) Pex3p-Myc is targeted and integrated into peroxisomal membranes. After the in vitro import assays, peroxisome and peroxisomes harboring Pex16p-HA fractions (B, left) were treated with 0.1 M Na~2~CO~3~. Membrane (M) and soluble (S) fractions were analyzed by SDS-PAGE and immunoblotting using antibodies to Myc, Pex14p, and a matrix enzyme, acyl-CoA oxidase (AOx). Only AOx-B chain was shown.](jcb1831275f05){#fig5}

Mechanism of Pex3p targeting mediated by Pex19p and Pex16p
----------------------------------------------------------

To assess the functional role, if any, of Pex3p mPTS distinct from Pex19p-binding region in the targeting of Pex3p--Pex19p complex to Pex16p, we likewise performed the transport reaction using the semi-intact cells expressing EGFP-Pex16p with cytosolic fraction containing HA-Pex19p and Pex3p-Myc or mPTS-deleted Pex3pΔN30-Myc. Pex3p-Myc was efficiently translocated to EGFP-Pex16p-positive particles (peroxisomes), whereas Pex3pΔN30-Myc apparently failed to target EGFP-Pex16p ([Fig. 6, A and B](#fig6){ref-type="fig"}). These data strongly suggested that Pex3p mPTS was essential for the Pex3p--Pex19p complex to translocate and bind to Pex16p on peroxisome membranes. Next, we attempted to delineate the roles of Pex16p and Pex19p in membrane targeting of Pex3p, using the full-length Pex3p-Myc and mPTS-containing Pex3p(1--50)-Myc that had been synthesized as such or together with HA-Pex19p in a cell-free translation system. In the Pex3p transport assays using semi-intact cells, ectopic expression of EGFP-Pex16p significantly enhanced the peroxisomal targeting of not only Pex3p-Myc but also Pex3p(1--50)-Myc ([Fig. 6 C, a, c, i, and k](#fig6){ref-type="fig"}). The Pex3p-Myc translocation to peroxisomes was specifically enhanced by its cotranslation with HA-Pex19p in both control and EGFP-Pex16p--expressing cells ([Fig. 6 C, a, b, i, and j](#fig6){ref-type="fig"}). However, no such apparent effect of HA-Pex19p was discernible on Pex3p(1--50)-Myc in both types of cells ([Fig. 6 C, c, d, k, and l](#fig6){ref-type="fig"}). Statistical analysis of these data confirmed the Pex16p- and Pex19p-dependent enhancement of the specific targeting of Pex3p-Myc as well as Pex16p-dependent but Pex19p-independent increase in translocation of Pex3p(1--50)-Myc ([Fig. 6 D](#fig6){ref-type="fig"}). Moreover, cell-free synthesized Pex3p-Myc and Pex3p(1--50)-Myc, but not Pex3pΔN30-Myc, were coimmunoprecipitated with Flag-Pex16p-HA, thereby indicating the direct binding of Pex3p as well as Pex3p(1--50) to Pex16p ([Fig. 7, A and B](#fig7){ref-type="fig"}). However, ectopically expressed Pex16p on peroxisome membranes did not recruit the cytosolic Pex19p in semi-intact cells (unpublished data). Collectively, it is most likely that Pex19p simply prevents Pex3p from mistargeting by its chaperoning activity and promotes Pex16p-dependent Pex3p targeting via interaction of the Pex3p mPTS with Pex16p.

![**N-terminal domain of Pex3p is essential for translocation to peroxisome membranes.** (A) N-terminal mPTS region of Pex3p is involved in docking to Pex16p. Pex3p import assay in semi-intact CHO-K1 was performed as in [Fig. 3 B](#fig3){ref-type="fig"}, with the cytosol fraction containing HA-Pex19p and Pex3p-Myc (left) or Pex3pΔN30-Myc truncated in 30 residues from the N terminus (right). EGFP-Pex16p and Myc-tagged Pex3p and Pex3pΔN30 were detected by GFP fluorescence and immunostaining with anti-Myc antibody. Bars, 10 μm. (B) Cytosol fractions used in A were verified by SDS-PAGE and immunoblotting. (C) N-terminal domain of Pex3p targets peroxisomes in a Pex16p-dependent but Pex19p-independent manner. Pex3p-Myc and Pex3p(1--50)-Myc were synthesized by cell-free translation (a, c, i, and k) or cotranslation with HA-Pex19p (b, d, j, and l) in a rabbit reticulocyte-lysate system. Supernatant fractions were incubated at 26°C for 1 h with semipermeabilized, CHO-K1 cells (a--h) and *EGFP-PEX16*--transfected CHO-K1 cells (i--p). Cells were stained with antibodies to Myc and Pex14p. EGFP-Pex16p (m--p) was detected by GFP fluorescence. Bars, 10 μm. (D) Peroxisome-targeting specificities of Pex3p-Myc and Pex3p(1--50)-Myc were determined by quantitative analysis of confocal images in C. Manders overlap coefficient ([@bib23]) between peroxisomes (marked by Pex14p or EGFP-Pex16p) and Pex3p-Myc or Pex3p(1--50)-Myc were calculated with ImageJ software. Values are means ± SD of at least three experiments. Pex3p-Myc: open bar, *n* = 4; diagonal bar, *n* = 3; dotted bar, *n* = 3; solid bar, *n* = 6. Pex3p(1--50)-Myc: all bars, *n* = 3. Note that peroxisome-targeting specificity of Pex3p(1--50)-Myc was dependent on Pex16p but not Pex19p.](jcb1831275f06){#fig6}

![**mPTS of Pex3p binds to Pex16p.** (A) Pex3p-Myc and Pex3pΔN30-Myc were synthesized in vitro by cotranslation with Flag-Pex16p-HA mRNA. The reaction mixture was centrifuged and the supernatant was subjected to immunoprecipitation (IP) with anti-Flag IgG agarose. Bound proteins were eluted with Flag peptides and analyzed by SDS-PAGE and immunoblotting with antibodies to Myc and HA. Lanes 1 and 2, 10% input of Pex3p-Myc and Pex3pΔN30-Myc; lanes 3 and 4, immunoprecipitates. (B) Flag-Pex16p-HA was likewise synthesized by cell-free translation with Pex3p(1--50)-Myc or Myc. Immunoprecipitation was done as in A. Lanes 1 and 2, 10% input of Pex3p(1--50)-Myc or Myc; lanes 3 and 4, immunoprecipitates. Dot indicates endogenous globin apparently cross reacting with anti-Myc antibody.](jcb1831275f07){#fig7}

Pex16p is the membrane receptor for Pex3p in vivo
-------------------------------------------------

To verify whether Pex16p functions as a membrane receptor for newly synthesized Pex3p in vivo, we first investigated Pex3p targeting in cells ectopically expressing Pex16p. CHO-K1 cells were transfected with *PEX3-Myc* or *Myc-PEX12* together with *PEX16(Δ66-81)-HA* coding for a Pex16p-HA mutant lacking the amino acid sequence 66--81 containing the mPTS ([@bib15]). Pex16p(Δ66-81)-HA was localized to ER-like structures ([Fig. 8 A, b](#fig8){ref-type="fig"}), which is consistent with our earlier finding ([@bib15]). Pex3p-Myc mostly coincided with Pex16p(Δ66-81)-HA, indicative of its translocation to such structures, even in the presence of peroxisomes ([Fig. 8 A, a--c](#fig8){ref-type="fig"}), whereas Myc-Pex12p was localized to peroxisomes as assessed by staining of Pex14p (d--f). Pex3p(1--50)-Myc was likewise targeted to Pex16p(Δ66-81)-HA--positive membranes ([Fig. 8 A, g--i](#fig8){ref-type="fig"}). We interpreted these results to mean that Pex16p recruits newly synthesized Pex3p to Pex16p-residing membranes in vivo, in a Pex3p mPTS-dependent manner.

![**Pex16p is the membrane receptor for Pex3p.** (A) Mislocalization of Pex16p induces mistargeting of coexpressed Pex3p in vivo. CHO-K1 cells were transfected with *PEX16(Δ66-81)-HA* together with *PEX3-Myc* (a--c), *Myc-PEX12* (d--f), or *PEX3(1--50)-Myc* (g--i). Cells were fixed and stained with antibodies to Myc (a, d, and g), HA (b, e, and h), and Pex14p (c, f, and i). Bars: (a--c and g--i) 20 μm; (d--f) 10 μm. (B) Depletion of Pex16p abrogates Pex3p targeting in vivo. HEK293 cells were transfected with siRNAs each for a control EGFP (a--f), *PEX13* (g--i), and *PEX16* (j--r). After 40 h, cells were transfected with *PEX3-Myc* (a--l), *HA-PEX11α* (m--o), and *PEX3-Myc* plus *HA-mPEX16*, a mutant *PEX16* with a silent mutation in the target sequence of *PEX16* siRNA (p--r). Pex3p-Myc, HA-Pex11pα, HA-mPex16p, Pex13p, Pex16p, and Pex14p were detected by cell staining using antibodies to Myc (a, d, g, j, and p), HA (m and q), Pex13p (b and h), Pex16p (e, k, and n), and Pex14p (c, f, i, l, o, and r), respectively. Bars, 10 μm. (C, a) Control siRNA-transfected or -mediated Pex16p or Pex13p knockdown cells were assessed for the level and subcellular localization of Pex3p-Myc by immunostaining. Cell phenotypes with respect to the localization of Pex3p-Myc were classified into three types, peroxisomal, nonperoxisomal, and both, and were represented as percentages of total cells counted. Values are means ± SD of three experiments. Control EGFP siRNA, *n* = 521; *PEX13* siRNA, *n* = 515; *PEX16* siRNAi, *n* = 519. (b) siRNA-mediated Pex16p knockdown cells were likewise verified for subcellular location of HA-Pex11pα, Pex3p-Myc, and Pex3p-Myc coexpressed with HA-mPex16p. HA-Pex11pα, *n* = 508; Pex3p-Myc, *n* = 519; Pex3p-Myc with HA-mPex16p, *n* = 651.](jcb1831275f08){#fig8}

To confirm the Pex16p-dependent peroxisomal targeting of newly synthesized Pex3p, we investigated Pex3p translocation in cells where Pex16p was knocked down. HEK293 cells were transfected with siRNAs each for Pex16p, Pex13p, and a control EGFP. At 40 h after the transfection, cells were transfected with plasmids each encoding Pex3p-Myc and HA-Pex11pα and were cultured for 12 h, fixed, and stained with specific antibodies. In cells transfected with control siRNA, Pex3p-Myc was colocalized with Pex14p, Pex16p, and Pex13p, hence indicating proper translocation of Pex3p-Myc to peroxisomes ([Fig. 8 B, a--f](#fig8){ref-type="fig"}). Pex3p-Myc was likewise transported to peroxisomes in Pex13p knockdown cells ([Fig. 8 B, g--i](#fig8){ref-type="fig"}). In contrast, in Pex16p knockdown cells, Pex3p-Myc was discernible predominantly in other organelles possibly including mitochondria ([Fig. 8 B, j--l](#fig8){ref-type="fig"}), whereas HA-Pex11pα was correctly targeted to peroxisomes (m--o). However, Pex3p-Myc import was not affected when *PEX16* siRNA was cotransfected with mutant *PEX16* siRNA containing a silence mutation in the sequence for Pex16p mPTS ([Fig. 8 B, p--r](#fig8){ref-type="fig"}). In these cells, Pex16p was detectable at a normal level ([Fig. 8 B, q](#fig8){ref-type="fig"}). Furthermore, we assessed Pex3p import-competent cells in several hundred cells where Pex16p or Pex13p was knocked down as well as in randomly selected cells transfected with a control siRNA. Statistic analysis of these data confirmed that the severe reduction of Pex16p gave rise to the specific defect in Pex3p import to peroxisomes ([Fig. 8 C](#fig8){ref-type="fig"}). Collectively, these results demonstrated that Pex16p was a prerequisite for peroxisomal targeting of newly synthesized Pex3p in vivo, functioning as the Pex3p membrane receptor.

Discussion
==========

Recent work ([@bib3]; [@bib17]) has proposed two mechanistically distinct pathways for the peroxisomal import of PMPs: the Pex3p- and Pex19p-dependent class I pathway and the Pex3p- and Pex19p-independent class II pathway. Categorization of the class II import pathway was largely based on the observation that Pex19p did not function as a chaperone and an import receptor for the mPTS of Pex3p. However, this work paid little attention to full-length Pex3p.

In the present work, we have shown that Pex19p plays an essential role as the chaperone for full-length Pex3p, as it also does for other class I PMPs. Knockdown of Pex19p inhibits peroxisomal targeting of newly synthesized full-length Pex3p ([Fig. 2](#fig2){ref-type="fig"}). In addition to the stabilization of Pex3p by Pex19p in the cytosol, the cytosolic Pex3p--Pex19p complexes are competent to translocate to peroxisomes ([Figs. 3](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"}). Moreover, we have demonstrated from the following that Pex16p functions as the Pex3p-docking site: (a) the higher level expression of Pex16p, but not other PMPs, significantly enhances the efficiency in peroxisomal targeting of not only Pex3p--Pex19p complexes in the cytosol but also the isolated cytosolic Pex3p--Pex19p complexes ([Fig. 3 B, Fig. 4 B](#fig3){ref-type="fig"}, Fig. S1, and Fig. S2) and cell-free synthesized Pex3p--Pex19p complexes ([Fig. 5](#fig5){ref-type="fig"}; and [Fig. 6, C and D](#fig6){ref-type="fig"}); (b) an ectopically expressed Pex16p variant lacking its mPTS recruits the Pex3p--Pex19p complexes to the membranes, such as ER harboring the Pex16p mutant ([Fig. 3 C](#fig3){ref-type="fig"}); (c) Pex16p directly interacts with Pex3p ([Fig. 7](#fig7){ref-type="fig"}); and (d) the siRNA-based knockdown of Pex16p abrogates peroxisomal targeting of newly synthesized Pex3p ([Fig. 8 B](#fig8){ref-type="fig"}). Taking these results together, we conclude that Pex16p plays both a necessary and a sufficient role in the selective targeting of Pex3p--Pex19p complexes.

We therefore propose a new classification of the pathways for the peroxisomal import of PMPs that depends on Pex19p-mediated membrane docking: (a) a class I pathway in which Pex3p functions as the membrane receptor, and (b) a class II pathway where Pex16p is the anchoring site. Under this new classification, the original class II pathway ([@bib3]; [@bib17]) for Pex3p--Pex19p--independent PMP import would (if its existence is confirmed) be included as an additional class III pathway.

Pex16p is known to be a class I PMP that is imported to peroxisomes by the Pex19p-dependent and Pex3p-mediated pathway ([@bib3]; [@bib17]; [@bib26]; [@bib28]). However, our study shows that Pex16p also functions as the membrane receptor for Pex3p. This raises an intriguing "chicken-and-egg" issue regarding the molecular events at the initial stages of peroxisome membrane biogenesis. Although we cannot yet provide a definitive resolution to this issue, we propose a consolidating model termed "mutual-dependent targeting," which both reconciles our findings and provides new mechanistic insights into peroxisome membrane biogenesis ([Fig. 9](#fig9){ref-type="fig"}). In this model, two types of membrane structures, initially harboring either Pex3p or Pex16p, are equally capable of developing into peroxisomes, implying that de novo membrane biogenesis may be initiated via two mutually distinct pathways. Peroxisome membranes are likely formed via these pathways, either independently or in a coordinated manner.

![**A model for early stages of peroxisomal membrane biogenesis involving mutually dependent targeting of Pex3p and Pex16p.** The initial membranes harboring Pex3p or Pex16p culminate in indistinguishable, matured peroxisomes.](jcb1831275f09){#fig9}

More recently, Pex16p was reported to function as a Pex3p receptor on ER membranes and to initiate de novo peroxisome membrane biogenesis from ER membranes ([@bib19]). However, such a functional role of Pex16p on ER membranes was deduced from the results obtained by an overexpression system. It still remains unclear how Pex16p is imported into ER membranes and whether Pex16p serves as a Pex3p receptor only on ER membranes. In the present study, we demonstrated that Pex3p was directly imported into peroxisomes and that Pex16p functioned as the Pex3p receptor on peroxisomal membranes ([Fig. 5](#fig5){ref-type="fig"}). We also confirmed these findings with the semi-intact cell system (unpublished data). Given that Pex3p functions as a peroxisomal import receptor for multiple class I PMPs, the directly providing step of Pex3p via Pex16p to the preexisting peroxisomes may be a prerequisite for the maintenance of the sufficient import of various class I PMPs.

With respect to Pex16p in other species, the yeast *Yarrowia lipolytica* Pex16p (YlPex16p; [@bib2]) shares 24% amino acid identity with the human Pex16p ([@bib14]). Despite the fact that intraperoxisomal peripheral membrane peroxin (YlPex16p) and an integral membrane protein (HsPex16p) are essential for peroxisome biogenesis, their roles do not appear to be identical ([@bib2]; [@bib43]; [@bib14]; [@bib42]; [@bib38]; [@bib39]). YlPex16p unlikely plays a role as the membrane receptor for YlPex3p. Furthermore, in *S. cerevisiae*, a *PEX16* homologue is not identified in the genome ([@bib38]; [@bib11]), where the ScPex3p- and ScPex19p-dependent class I PMP import pathway is conserved ([@bib3]). These observations imply that Pex16p-mediated regulation of Pex3p import is not conserved between yeast and mammalian cells and suggest the possibility that such a function of Pex16p may have evolved later in mammalian cells ([@bib36]). The functional roles of mammalian Pex16p may be fulfilled by other peroxins, if any, in *Y. lipolytica* and *S. cerevisiae*. It is also equally possible that there may be other mechanisms underlying the Pex3p import in these species, as suggested previously ([@bib13]; [@bib21]; [@bib40]). Addressing such issues would provide a comprehensive understanding of the molecular mechanisms that govern peroxisome membrane biogenesis in eukaryotic cells.

Materials and methods
=====================

Cell culture and antibodies
---------------------------

CHO-K1 and HEK293 cells were cultured as described previously ([@bib24]; [@bib45]). Rabbit antibodies to acyl-CoA oxidase ([@bib45]), Pex3p ([@bib8]), Pex19p ([@bib27]), Pex14p ([@bib37]), Pex13p ([@bib44]), Pex16p ([@bib14]), HA ([@bib33]), lactate dehydrogenase ([@bib29]), and guinea pig anti-Pex14p antibody ([@bib30]) were as described previously. Rabbit anti-human Sec61pβ antibody (Millipore) and monoclonal antibodies to c-Myc (9E10; Santa Cruz Biotechnology, Inc.), Flag (M2) (Sigma-Aldrich), HA (16B2) (Covance), α-tubulin (Clontech Laboratories, Inc.), and GFP (B2) (Santa Cruz Biotechnology, Inc.) were purchased.

Construction and transfection of epitope-tagged or EGFP-fused *PEX* cDNAs
-------------------------------------------------------------------------

DNA transfection into CHO cells was performed using Lipofectamine (Invitrogen; [@bib32]). We used rat *Flag-PEX3*, rat *Flag-PEX3-HA*, rat *PEX3-EGFP*, rat *Flag-PEX3-EGFP*, rat *Flag-PEX3ΔN30-EGFP* ([@bib8]), human *HA-PEX19*, human *HA-PEX19ΔN23* ([@bib26]), human *Flag-PEX16-HA*, *PEX16-HA*, and *EGFP-PEX16* ([@bib14], [@bib15]), rat *PEX12-Myc* ([@bib32]), human *PMP22-EGFP* ([@bib15]), human *PMP70-EGFP* ([@bib20]), and human *PEX26-HA* ([@bib24]). Epitope tagging and EGFP fusion to these peroxins did not affect the respective biological activities as in the cited references. Rat *PEX14-EGFP*, Chinese hamster *HA-PEX13*, rat *HA-PEX12*, human *HA-PEX10*, rat *HA-PEX2*, and human *HA-PEX11α* were likewise constructed as done for *PMP22-EGFP* and other *HA-PEX*s.

For rat *PEX3-Myc* and *PEX3(1--50)-Myc*, HindIII--BamHI fragments of PCR products generated using *pUcD2Hyg*/*Flag-RnPEX3* ([@bib8]) as a template with a set of primers, 3F and 3R ([Table I](#tbl1){ref-type="table"}) for *PEX3* and 3F and 3(1--50)R for *PEX3(1--50)*, were inserted into the HindIII--ApaI sites of pcDNA3.1/Zeo(+) (Invitrogen), together with the BamHI--ApaI fragment of pCMV-*6Myc*(N) (a gift from K. Tsuchida, Tokushima University, Tokushima, Japan). *SS-HA-HsPEX16* and *SS-HA-HsPEX11α* were generated by two-step PCR. For the first PCR, a set of forward and reverse primers, 16HA2F for *PEX16* ([@bib14]) and 11αHA2F for *HsPEX11α* ([@bib1]), were used, and resulting fragments were used as a template for the second PCR. For the second PCR, a set of forward and reverse primers, SSF and 16R for *PEX16* and SSF and 11αR for *PEX11α*, were used. KpnI--XbaI fragment of the respective second PCR products was inserted into KpnI--XbaI sites of pcDNA3.1/Neo(+) vector (Invitrogen). To construct *HA-mPEX16*, two-step PCR was done. For the first PCR, a pair of forward and reverse primers, 16HA2F and m16R plus m16F and 16R, were used, and resulting fragments were mixed and used as a template for the second PCR. Second PCR was performed using a set of forward and reverse primers, 16HA2F and 16R. BamHI--XbaI fragment of the second PCR product was inserted into BamHI--XbaI sites in pcDNA3.1/Zeo(+) vector.

###### Synthetic oligonucleotide primers used

  -------------------------------------------------------------------------------------------------------------------
  Code        Sequence (5′ to 3′)                                Underlined\
                                                                 (nucleotide sequence at)
  ----------- -------------------------------------------------- ----------------------------------------------------
  3F          CCCAAGCTT[ATGCTGAGATCAATGTGGAAT]{.ul}              1--21 of rat *PEX3*

  3R          CGCGGATCC[TTTCTCCAGTTGTTGGGGGGT]{.ul}              1096--1116 of rat *PEX3*

  3(1--50)R   CGCGGATCC[GGCAATGTACTCTGCAGCTTC]{.ul}              130--150 of rat *PEX3*

  16HA2F      GCTGGATCCATGGCG[TACCCCTACGATGTGCCCGATTA]{.ul}\     Tandem *HA* (tagging to human *PEX16*)
              [TGCATACCCCTACGATGTGCCCGATTATGCA]{.ul}ATGGAGA\     
              AGCTGCGGCTCCTGGGC                                  

  16R         GCTCTAGA[TCAGCCCCAACTGTAGAAGTA]{.ul}               991--1000 plus a stop codon of human *PEX16*

  11αHA2F     GCTGGATCCATGGCG[TACCCCTACGATGTGCCCGATTA]{.ul}\     Tandem *HA* (tagging to human *PEX11α*)
              [TGCATACCCCTACGATGTGCCCGATTATGCA]{.ul}ATGGACG\     
              CCTTCACCCGCTTCACC                                  

  11αR        GCTCTAGA[CTAACGGGTCTTCAGCTTCAT]{.ul}               724--741 plus a stop codon of human *PEX11α*

  SSF         CGGGGTACCGCC[ATGGGAGCTGCTGCAAAGTTGGCGTT]{.ul}\     Signal sequence of mouse activin type IIA receptor
              [CGCCGTCTTTCTTATCTCTTGCTCTTCAGGTGCTATACTT]{.ul}\   
              [GGCAGA]{.ul}TACCCATACGATGTTCCAGATTACGCTGGATCC\    
              ATGGCG                                             

  m16R        GCTCAGCCATGTCAGCAGCTTCTGCTGGGACAGCGACAC\           A silence mutation in human *PEX16*
              [TGGGAGTTTCTTTCTCAATTCTTT]{.ul}CCGTAGGATCCCGTCA\   
              TTGAG                                              

  m16F        AAGCTGCTGACATGGCTGAGCGTGCTGGAGTGCGTG[GAA]{.ul}\    A silence mutation in human *PEX16*
              [GTCTTT]{.ul}ATG[GAA]{.ul}ATG[GGC]{.ul}GCT         
  -------------------------------------------------------------------------------------------------------------------

F and R, forward and reverse primers, respectively.

We confirmed the complementing activity of *PEX14-EGFP*, *HA-PEX13*, *HA-PEX12*, *HA-PEX10*, *HA-PEX2*, *and PEX3-Myc*, using respective *PEX-*defective mutants, and the peroxisome division activity of *HA-PEX11α* with wild-type CHO cells.

Morphological analysis
----------------------

Cell fixing ([@bib41]) and immunostaining with secondary antibodies labeled with Alexa 488, 568, and 633 (Invitrogen) were as described previously ([@bib32]). Cells were observed under a confocal microscope (LSM 510; Carl Zeiss, Inc.). Images were acquired and analyzed with an LSM image browser (Carl Zeiss, Inc.) and ImageJ software (National Institutes of Health).

Preparation of semi-intact cells
--------------------------------

Cells grown on 18-mm coverglass were incubated for 10 min on ice with 5% BSA in semi-intact cell buffer (SB): 0.25 M sucrose, 25 mM Hepes-KOH, pH 7.4, 2.5 mM magnesium acetate, 2.5 mM KCl, 2 mM EGTA, 0.5 μM Taxol, and protease inhibitor cocktail. After thoroughly washing with ice-cold SB, cells were incubated with 25 μg/ml digitonin in SB for 5 min at room temperature, washed three times with ice-cold SB, and incubated in SB for 30 min on ice. Lactate dehydrogenase, a cytosolic marker protein, was not discernible in the semi-permeabilized cells by immunostaining with specific antibody, hence confirming the efficient removal of the cytosol. About 80% cells were permeabilized under this condition. To assay in vitro targeting to ER membranes, CHO-K1 cells transfected with *SS-HA-PEX16* or *SS-HA-PEX11α* were permeabilized with 0.1% digitonin.

In vitro targeting assay
------------------------

Semipermeabilized cells were incubated in SB with the cytosol fraction isolated from CHO-K1 cells expressing epitope-tagged Pex3p and Pex19p, washed three times with ice-cold SB, and further washed with ice-cold SB on ice for 30 min at 10-min intervals. Cells were fixed and subjected to morphological and Western blot analyses. To assess the targeting of cytosolic Pex3p stabilized by Pex19p to endogenous peroxisomes including those from CHO-K1 cells stably expressing Pex16p-HA as prepared previously ([@bib15]), targeting assay was performed at 26°C for 1 h (unless otherwise described). To evaluate the effect of ectopically and transiently expressed PMPs on the peroxisomal targeting efficiency of Pex3p--Pex19p complexes in the cytosol, targeting assay was done at 4°C for 30 min. For in vitro targeting assays using cell-free synthesized Pex3p-Myc and Pex3p(1--50)-Myc, the translation reaction mixtures were diluted with SB and incubated at 26°C for 1 h with semipermeabilized CHO-K1 cells and those expressing EGFP-Pex16p.

In vitro import assay
---------------------

In vitro Pex3p-Myc import assay was performed in SB for 1 h at 26°C using cell-free synthesized Pex3p-Myc and peroxisomes isolated from CHO-K1 and CHO-K1 cells stably expressing Pex16p-HA by OptiPrep density gradient ultracentrifugation (see section below). After the reaction, peroxisomes were recovered by centrifugation at 20,000 *g* for 20 min. Import of Pex3p-Myc to peroxisomes was verified by its resistance to the alkaline treatment ([@bib5]). Membrane and soluble fractions were separated by centrifugation at 20,000 *g* for 20 min.

Pulse-chase experiment
----------------------

CHO-K1 cells were transfected with *Flag-PEX3-HA* or *Flag-PEX3-HA* plus *PEX19*. After 24-h culture, cells were pulse-labeled with 100 μCi/ml \[^35^S\]methionine plus \[^35^S\]cysteine (GE Healthcare) and chased for 6 h ([@bib45]). Flag-Pex3p-HA was immunoprecipitated from cell lysates with rabbit anti-HA antibody ([@bib33]) and analyzed by SDS-PAGE and autoradiography with a FLA-5000 Imaging System analyzer (Fujifilm; [@bib29]). Total amounts of the immunoprecipitated Flag-Pex3p-HA were determined by immunoblotting with mouse anti-HA antibody.

OptiPrep density gradient ultracentrifugation
---------------------------------------------

All steps were performed at 4°C. CHO-K1 cells and those stably expressing Pex16p-HA were homogenized in homogenize buffer (HB; 0.25 M sucrose, 20 mM Hepes-KOH, pH 7.4, 1 mM EDTA, and protease inhibitors) and centrifuged at 1,000 *g* for 10 min to yield postnuclear supernatant (PNS) fraction. Total organelle fractions were prepared by floatation on a sucrose step gradient by centrifugation in a rotor (SW55Ti; Beckman Coulter) at 55,000 rpm for 2 h. The organelle fractions were recovered from the 1.6--0.25-M interface. Peroxisomes were isolated by ultracentrifugation of the organelle fractions in 23% OptiPrep density gradient ([@bib47]), with a rotor (NVT65.2; Beckman Coulter) at 46,000 rpm for 3 h ([@bib16]). 10 1-ml fractions were collected and analyzed by SDS-PAGE and Western blotting.

RNAi
----

Endogenous Pex16p and Pex13p in HEK293 cells were knocked down with 100 nM siRNAs each designed for targeting human *PEX16* exon 3 and human *PEX13* exon 2 (Silencer Pre-Designed siRNA; Applied Biosystems) by transfection using siPORT Amine Transfection Agent (Applied Biosystems). As a transfection control, we used an equal amount of siRNA targeting the following sequences of *EGFP* (sense, 5′-GCAGCACGACUUCUUCAAGtt-3′; antisense, 5′-CUUGAAGAAGUCGUGCUGCtt-3′; Silencer siRNA). After 40-h incubation, cells were transfected with plasmids each for Pex3p-Myc, HA-Pex11pα, and HAmPex16p (product of a *PEX16* mutant with a silent mutation in the target sequence of siRNA) and were cultured for 12 h. To inhibit endogenous Pex19p, HEK293 cells were treated with 100 nM siRNA designed for targeting human *PEX19* (ON-TARGET*plus* SMARTpool siRNA; Thermo Fisher Scientific) twice at a 24-h interval using DharmaFECT1 transfection reagent (Thermo Fisher Scientific). As a transfection control, we used an equal amount of control siRNA (siCONTROL Non-targeting siRNA pool; Thermo Fisher Scientific). At 48 h after the first siRNA treatment, cells were transfected with plasmids each for Pex3p-Myc and Pex3p(1--50)-Myc and were cultured for 24 h.

Other methods
-------------

In vitro transcription/translation ([@bib29]), in vitro binding assays ([@bib33]) using in vitro synthesized Pex3p-Myc, Pex3p(1--50)-Myc, Flag-Pex16p-HA, and Myc (pCMV-*6Myc*(N) vector product), and subcellular fractionation and Western blotting ([@bib33]) were done as described previously. Immunoprecipitation from cytosol fractions was done with anti-HA antibody or preimmune sera after the dilution with an equal volume of 1% digitonin, 20 mM Hepes-KOH, pH 7.4, 0.3 M NaCl, 1 mM EDTA, and protease inhibitors.

Online supplemental material
----------------------------

Fig. S1 (supplement to [Fig. 3](#fig3){ref-type="fig"}) shows that Pex16p recruits Pex3p--Pex19p complexes. Fig. S2 shows that the elevated level of membrane-integrated Pex16p enhances the efficiency of Pex19p-mediated Pex3p targeting. Fig. S3 shows that Pex3p targeted to Pex16p is integrated into the peroxisomal membranes in a temperature-dependent and ATP-independent manner. Fig. S4 shows that the full-length Pex16p is required for recruiting cytosolic Pex3p--Pex19p complexes to peroxisomes. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.200806062/DC1>.
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